| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,407 |
10,370 |
$519K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,231 |
1,196 |
$95K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,030 |
984 |
$80K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,752 |
2,600 |
$76K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,671 |
1,538 |
$65K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,347 |
2,451 |
$55K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
679 |
632 |
$54K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
715 |
660 |
$52K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
950 |
845 |
$47K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,457 |
3,111 |
$46K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
682 |
637 |
$30K |
| 99429 |
|
728 |
713 |
$24K |
| 92587 |
|
1,882 |
1,786 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
142 |
138 |
$10K |
| 99000 |
|
1,146 |
1,061 |
$10K |
| 90461 |
|
3,267 |
1,268 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,100 |
804 |
$9K |
| 87807 |
|
779 |
707 |
$8K |
| 99050 |
|
528 |
499 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
110 |
109 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
413 |
347 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
115 |
113 |
$3K |
| 90715 |
|
152 |
147 |
$3K |
| 90686 |
|
768 |
744 |
$1K |
| 87634 |
|
26 |
26 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
51 |
45 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
71 |
70 |
$1K |
| 96160 |
|
414 |
389 |
$688.47 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
55 |
55 |
$479.81 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
115 |
86 |
$141.44 |
| 96161 |
|
147 |
144 |
$83.25 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
41 |
38 |
$38.28 |
| 90677 |
|
137 |
133 |
$0.26 |
| 90651 |
|
37 |
37 |
$0.05 |
| 99173 |
|
1,958 |
1,852 |
$0.00 |
| 90633 |
|
111 |
109 |
$0.00 |
| 90670 |
|
504 |
482 |
$0.00 |
| 90710 |
|
145 |
139 |
$0.00 |
| 90734 |
|
102 |
95 |
$0.00 |
| 90700 |
|
14 |
14 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
502 |
465 |
$0.00 |
| 90647 |
|
367 |
352 |
$0.00 |
| 90680 |
|
362 |
345 |
$0.00 |
| 90723 |
|
94 |
86 |
$0.00 |
| 36416 |
|
70 |
68 |
$0.00 |
| 90698 |
|
15 |
14 |
$0.00 |
| 90696 |
|
15 |
15 |
$0.00 |